ELANE: an emerging lane to selective anticancer therapy
Crossref DOI link: https://doi.org/10.1038/s41392-021-00766-2
Published Online: 2021-10-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peng, Boqiang
Hu, Jiankun
Fu, Xianghui http://orcid.org/0000-0001-9808-3892
Text and Data Mining valid from 2021-10-01
Version of Record valid from 2021-10-01
Article History
Received: 16 June 2021
Revised: 6 September 2021
Accepted: 13 September 2021
First Online: 1 October 2021
Competing interests
: The authors declare no competing interests.